Drug Trial Radar · NCT05636228
Study of INV-102 Ophthalmic Solution in Adults With Acute Infectious Keratoconjunctivitis
Last checked: Nov 19, 2026Latest source record: Sep 18, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
93
Actual
Start
Jun 9, 2023
Primary completion
Aug 22, 2024
Study completion Aug 22, 2024
Sponsor
- Lead sponsor
- Invirsa, Inc.Industry
- Sponsor type
- Industry
- Collaborators
- Biomedical Advanced Research and Development Authority
- First posted
- Dec 5, 2022
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Phase 2, randomized study to assess topically administered eyedrops of INV-102 compared to vehicle during 1-week dosing in participants with Acute Infectious Keratoconjunctivitis (AIK). Participants will return for a follow up visit 1 week after end of treatment.
Conditions
- Acute Infectious Keratoconjunctivitis
Interventions
INV-102Drug
INV-102 Ophthalmic Solution
VehicleDrug
Vehicle Ophthalmic Solution
Primary outcomes
What the sponsor says the trial is designed to measure.
- To Evaluate the Change in Combined Clinical ScoreTime frame: Through End of Treatment (Day 8)
Locations
12 sites in 2 countries. Site status is shown where the registry gives one.
Global Research Management
Glendale, California
Foothill Eye Institute
Pasadena, California
Shettle Eye Research
Largo, Florida
D & H National Research Centers, INC
Miami, Florida
My Community Research Center, Inc.
Miami, Florida
Quantum Clinical Trials
Miami Beach, Florida
Kannarr Eye Center
Pittsburg, Kansas
Oculos Clinical Research
Garner, North Carolina
Athens Eye Care
Athens, Ohio
Revolution Research/ Lake Travis Eye and Laser Center
Lakeway, Texas
King Chulalongkorn Memorial Hospital
Bangkok, Thailand
Mahidol university
Bangkok, Thailand
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.